Immedica expands into the U.S., establishes Chicago-based commercial business
Stockholm, September 9, 2024 – Immedica Pharma AB, a global pharmaceutical company dedicated to addressing rare and severe diseases, is excited to announce the establishment of its U.S. commercial business, Immedica Pharma US Inc. headquartered in Chicago. With a strong presence in Europe and the Middle East, Immedica’s entry into the U.S. market underscores its ambition to become a global leader in the rare disease sector. The new entity will focus on introducing innovative therapies to the U.S. market, aiming to expand the range of available treatment options. “This expansion into